The overall increased risk of serious adverse effects, such as breast cancer, stroke and pulmonary embolism, with long-term hormone replacement therapy (HRT). According to a review of major trials published last week, the overall increased risk of serious adverse effects, such as breast cancer, stroke and pulmonary embolism, with long-term hormone replacement therapy (HRT) outweighs the potential benefits in preventing diseases. In the past, hormone therapy was routinely used to treat menopausal symptoms and protect long-term health. Then, large clinical trials showed health risks. What does this mean for you? Hormone replacement therapy was associated with an increased risk of fecal incontinence, fibroids, gallbladder disease and gallstones, hearing loss, joint inflammation, rheumatoid arthritis, and urinary incontinence (68,69,97,112-11).
Many of these potential risks also relate to general health and family history of illnesses.) It's important to discuss your individual risk with your provider. There is some evidence that long-term use of hormonal hormone therapy may increase the risk of certain health conditions, such as breast cancer, endometrial cancer, and the formation of blood clots. The side effects of hormone therapy may last for a short time or may last until the end of treatment and beyond. In a Cochrane review (it was suggested that, compared to combined hormone replacement therapy, tibolone had no effect on cardiovascular, cerebrovascular, or thromboembolic events).
Although they can save lives, some chemotherapy and hormone therapies used to treat breast cancer can cause temporary or permanent menopause. Three studies that used estrogen alone or had no effect on breast cancer risk compared to unspecified hormone therapy (79.85.8). If you have menopausal symptoms that affect your quality of life, you may wonder if hormone therapy it's an option for you. To find out if menopausal hormone therapy is a good option for you, talk to your health professional about your symptoms and health risks.
You should also review the use of hormone therapy regularly with your healthcare professional to ensure that the benefits continue to outweigh the risks. Tibolone showed inconsistent effects on breast cancer: two analyses showed no association with breast cancer and two others suggested an increased risk of breast cancer compared to placebo, the absence of hormone therapy or combined hormonal therapy (10, 8). Compound hormones aren't well studied and health professionals aren't sure of their long-term effects.) People who lose estrogen too soon (before age 40) often receive higher doses to replace what their ovaries would normally produce for their age. It's important to make the decision to take hormone therapy after talking with your healthcare provider.
The increased risk of ovarian cancer is already recognized in the technical specifications of hormone replacement therapy products. The results were inconsistent: one study found no effect and another found a lower risk of coronary heart disease with hormone replacement therapy. Hormone therapy (HT) is a broader term, meaning it can be applied to any type of treatment that involves hormones. This form of hormone therapy combines doses of estrogen and progesterone (also called progestin, which is the name for all the hormones that act like progesterone, including synthetic ones).
Having a strong social and emotional support system can also help you during hormone therapy. for cancer.
